Freshfields advises PhenomeX in its $108 million sale to Bruker

Freshfields advises PhenomeX, a functional cell biology company, in its agreement to sell to Bruker Corporation for $1.00 per share in an all-cash transaction. The proposed acquisition values PhenomeX at a total equity value of approximately $108 million. Learn more about the details of the transaction here.

The Freshfields deal team included M&A lawyers Damien Zoubek, Oliver Board, Brian Kloeblen and Clara Barnosky; executive compensation/benefits lawyers Brandon Gantus, Andrew Herman and Sonia Bennett; tax lawyers Joe Soltis and Brendan Counihan; IP and life sciences lawyer Vinita Kailasanath; IP lawyers Sora Park and Jake Silvers; leveraged finance lawyers Allison Liff, Meghan Bell and Nicholas Mack and antitrust lawyers Meghan Rissmiller, Ally Ampudia and Lauren Vaca.